Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse by Bernsen, H.J.J.A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/21465
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
British Journal of Cancer (1995) 71,721-726 
©  1995 Stockton Press All rights reserved 0007-0920/95 $12,00
Vascularity and perfusion of human gliomas xenografted in the athymie 
nude mouse
HJJA Bernsen12, PFJW Rijken1, T Oostendorp1 and AJ van der Kogel1
1Institute of Radiotherapy, University of Nijmegen, The Netherlands; 2Department of Neurology, Canisius-Wilhelmina Hospital, 
Nijmegen, The Netherlands
Summary The vascularisation and perfusion of seven subcutaneously xenografted human glioma lines 
established from surgical specimens has been analysed using an anti-collagen type IV antibody to visualise the 
vascular walls in combination with a perfusion marker (Hoechst 33342). A computer-based digital image 
processing system was employed for quantitative analysis of the parameters. The vascular architecture of 
individual tumours belonging to the same tumour line showed a consistent similarity, while substantial 
differences occurred between the various tumour lines derived from different patients. Despite the presence of a 
large inter-tumour variation in vascular area as a proportion of the tumour area, this vascular parameter 
clearly showed tumour line-specific characteristics. The perfused fraction of the tumour vessels also showed a 
large inter-tumour variation for all tumour lines ranging from 20% to 85%, but the majority of tumours of all 
lines had perfusion fractions of more than 55%. Despite large variation, the perfused vascular area as a 
proportion of the tumour cross-sectional area exhibited clear tumour line-specific tendencies. These observa­
tions suggest that consistent differences in vascular parameters are present between glioma xenograft lines, 
although the tumour lines all originated from histologically similar human high-grade gliomas. These differ­
ences may have important consequences for treatment and clinical behaviour of this type of tumour.
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Neovascularisation is a prerequisite for expansive growth of 
solid tumours and is correlated with the potential for meta­
stasis. (Weidner et al., 1991; Folkman and Shing, 1992). It is 
now well established that the vascular system of tumours is, 
however, very inefficient. Great variations in regional blood 
flow and intermittent perfusion of the vascular bed are 
reported to be present in a variety of tumours (Trotter et al., 
1989; Farrell et al., 1991). Morphological abnormalities in 
vascular structures and increased intratumoral pressure may 
at least in part be responsible for these observations (Vaupel 
et al., 1987; Jain, 1988, 1991). It has become clear that these 
phenomena have great significance for tumour metabolism 
and contribute to increased resistance to radiotherapy owing 
to regional hypoxia while incomplete tissue perfusion results 
in limitations in drug delivery (Vaupel et al., 1987, 1989; 
Jain, 1991). Gliomas are characterised by an exceptionally 
high degree of vascularisation (Brem et al.„ 1972; Boucher 
and Jain, 1992). This high degree of vascularisation may be 
related to the malignant behaviour of these tumours and 
reflects ,the high angiogenic potential of glioma 
understand the mechanisms involved in the process of neo­
vascularisation and tumour progression and its relevance for 
tumour biological behaviour and therapy response (prog*
o
nosis), assessment of and functional
aspects of the vascular system is necessary (Brem et al., 1972, 
1990). In general, morphological aspects are analysed using 
stereological principles such as the point counting method 
(Chalkley, 1943) and functional information is obtained
lamina of blood vessels and tumour perfusion was visualised 
with the fluorescent perfusion marker Hoechst 33342. A 
computer-based digital image processing system was em­
ployed for quantitative analysis of the parameters.
Materials and methods
Tumours
Tumours used in this study were derived from seven different 
primary human gliomas which were passaged 3-7 times 
subcutaneously in nude mice (Balb/c nu/nu mouse). In this 
study we use the terminology tumour line to indicate the 
collection of tumours derived from the same primary human 
tumour.
Forty tumours were investigated; from each tumour line
several passages were examined. Tumour weight ranged from 
0.06 to 0.47 g. The experimental procedures were approved 
by the local ethical committee for animal use.
Immunohistochemical staining and perfusion marker
Athymic mice bearing a subcutaneous human glioma in the 
right flank were injected intravenously via one of the lateral 
tail veins with 0.05 ml of a solution of PBS (phosphate- 
buffered saline, pH 7.4) containing 15 mg kg“1 of the per­
fusion marker Hoechst 33342 (Sigma, St Louis, MO, USA).
using autoradiographic methods or by contrast fluids or To prevent diffusion of Hoechst 33342 to adjacent non-
perfusion markers injected into blood vessels and thereby perfused vascular structures, mice were killed 1 miti after
delineating perfused areas (Jain, 1988; Trotter et al., 1989). injection. Tumours were quickly removed and frozen and
In most reports only morphological or only functional stored in liquid nitrogen. Frozen tissue sections, Sjtm thick,
aspects are studied. In this study we have analysed simul- were made using a freeze microtome. Four sections were
taneously the patterns of vascularisation and perfusion of taken from the central tumour region and four sections from
subcutaneously growing xenografts of seven different human the peripheral locations. As marker of the basal lamina of
gliomas implanted in athymic mice. Vascular morphology the tumour microvasculature an antibody against the basal
was visualised with an antibody directed against the basal lamina component collagen type IV was used (rabbit poly­
clonal antibody Collagen Type IV, Euro-Diagnostics BV, 
Oss, The Netherlands). This staining could be visualised in 
the fluorescence microscope (Axiovert, Zeiss) using an 
immunohistochemical procedure with as second antibody
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goat anti-rabbit immunoglobulin (TRITC labelled, Tago, 
Burlingame, CA, USA). As a first step frozen sections were 
air dried and fixed in acetone for 3 min. Then they were
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washed in PBS for lOmin. Subsequently sections were pro- (RVA) was expressed as the total surface of all vascular
the tumour area.
Perfused vessel area iDr W  Total vessel area ,*> v  A ^
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{ } total tumour area1 'total vessel area
cessed at room temperature by a 45 min incubation with the structures divided by the total tumour surface. The relative 
antibody collagen type IV, 10 min washing in PBS and then perfused tumour area (RPTA) was defined as the product of 
a 30 min incubation followed by the second antibody. This RVA and PF, that is the perfused vascular area divided by 
procedure resulted in an excellent fluorescent signal of the 
vascular pattern as could be detected by the fluorescence 
microscope with the 510-560 nm excitation and 590 nm 
emission Alter. There was a minimal background staining 
which did not interfere with the interpretation of the fluores­
cent signal. In the fluorescence microscope Hoechst 33342 
could be visualised in ultraviolet light showing a blue fluo­
rescence (filter with excitation at 365 nm and emission at 
420 nm) in the same sections as stained with collagen type 
IV. The stain Hoechst 33342 specifically labelled the nuclei of 
the cells adjacent to the vessel walls, thereby delineating the 
perfused vessels (Figure 1).
Perfused vessel area 
total tumour area
(RPTA)
This value reflects the perfused area of vascular structures 
per unit tumour area.
Whole tumour sections were by a computer-
controlled procedure using a high-resolution intensified solid- 
state camera for quantitative analysis. A detailed description 
of this method is given by Rijken et al. (submitted). Briefly, 
each tumour section was completely scanned twice with the 
fluorescence microscope using the two different filters. After 
processing all fields (field size 1.22 mm2, 10 X objective) of 
each scan the scanned area was reconstructed from the sepa­
rate processed images into one large image. This resulted in 
two composite images, one with the vascular structures (as 
stained by collagen IV) and another with the perfused areas 
(Hoechst).
When both composite images were combined the overlap­
ping structures represented those vascular structures which 
were perfused by Hoechst at the time of injection (perfused 
vascular area). The area of these overlapping structures 
divided by the total vascular area yielded the perfusion frac­
tion (PF) in this section, indicating the fraction of vessel 
structures that were perfused. The relative vascular area
Figure 1 Delineation of perfused blood vessels by the perfusion 
marker Hoechst 33342 staining the nuclei adjacent to perfused 
vessels ( x 200).
Histology
Haematoxylin and eosin-stained sections adjacent to the sec­
tions used for quantitative analysis of vessel structures and 
perfusion were made for histological examination. Hema­
toxylin and eosin-stained sections of biopsies from the
primary tumour were also examined histologically and com­
pared with xenografts derived from these tumours.
Statistics
The means of the measurement of the four central and/or 
peripheral sections for each tumour were used for further 
statistical analysis.
For each tumour line the vascular parameters (RVA, PF 
and RPTA) were compared between central and peripheral 
regions by means of a paired Student’s t test. For both 
peripheral and central regions as well as for the whole 
tumour, statistical comparison of PF, RVA and RPTA 
between the tumour lines was done using the analysis of 
covariance controlling for tumour weight. To determine 
where these differences in the means of any two groups was 
present, the Tukey test for multiple comparisons was applied. 
A /’-value below 0.05 was considered statistically 
significant.
Results
Morphology of parent human tumours and xenografts
Haematoxylin and eosin-stained sections were made for his­
tological examination. In Table I the histology of primary 
tumours and xenografts is presented. The xenografts were 
composed of densely packed tumour cells of medium size. 
The tumour cells showed marked nuclear polymorphism. The 
number of mitoses varied from 2 4 per 
(E l8, E49, E l20) to 6 8 per high-power field (E2, E80, E98, 
El 10). Delicate librovascular septa were present in all xeno­
grafts. Dispersed small areas of necrosis were seen in tumour 
lines E l8, E49 and E80. Pseudo-pallisading of tumour cells 
around areas of necrosis was observed in tumour line E80. 
Bizarre multinucleate giant cells were present in El 10. In our 
study we did not find a consistent relationship between histo- 
pathological characteristics and vascular parameters. More
specifically, scattered necrosis was sometimes observed in 
perfused tumour regions as well as in apparently vital areas 
in non-perfused tumour regions.
Vascular architecture
Tumours belonging to the same tumour line were found to 
have consistently similar vascular appearances, even up to 
seven passages, there were, however, clear differences in vas­
cular patterns between tumours from different tumour lines, 
as shown in Figure 2. This figure demonstrates the charac­
teristic aspects of vascular architecture of the seven glioma 
xenografts. It can be seen that the tumour line E2 is com­
posed of numerous very small and short vessel structures 
which are homogenously distributed. Tumour lines E l20 and 
El 8 show abundant vascular structures which are homogene-
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Patient
Age Xenografts
7’amour Histology Sc. v ( vears) * Mitoses Necrosis Special features
E2 AA M 33 6 - 8 — »
EI8 GBM F 46 2-4 + Cysts
E49 GBM F 48 2 4 +
E80 GBM M 70 6-8 -f Cysts, PP
E98 GBM M 69 6 8 — ■. V *. .  .m  Ik
E110 GBM M 56 6 8 M NG Cell
E120 GBM F 66 2 ~ 4 1
A A, anaplastic astrocytoma; GBM , glioblastoma multiforme; F, female; M, male; PP, 
pseudo pallisading cells; M NG, multinucleated giant cells.
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various tumour lines (see Table II and Figure 3a) meaning 
7 14% of the tumour area in a section was occupied by 
vascular structures. As reflected in the coefficient of variance 
(CV), there was a large inter-tumour variability for RVA in 
one tumour line. Within the same tumour line the mean 
relative vascular area was usually lower in the central sec­
tions than in the peripheral sections. Only in the line E l20 
this difference is significant (P <0.05, paired Student’s /-test). 
Significant differences in relative vascular area could also be 
demonstrated between several tumour lines. Considering the 
total mean RVA, tumour lines E80, El 10 and E l20 were 
found to have significantly larger vascular areas than E2 and 
E49 (P<0.05, Tukey test). The significant differences in 
RVA for the different glioma xenografts are summarised in 
Table III.
The observations on both vascular architecture and vas­
cular area indicate that characteristic differences in the degree 
of vascularisation exist between the various tumour lines. No 
correlation was found between tumour weight and RVA.
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Figure 2 images of vascular architecture of seven
glioma xenograft lines. Complete sections through the middle of 
the tumour are presented for all seven tumour lines illustrating 
the characteristic vascular patterns for the individual tumour 
lines. All tumours belonging to the same tumour line showed 
identical vascular arrangements ( x 25).
Perfusion fraction
As can be seen in Figure 3b the perfusion fraction showed a 
large variation for all tumour lines and for both central and 
peripheral regions, ranging from 20% to 85% (see cvPF in 
Table II). Perfusion fractions of 20 40% were seen for only 
one or two tumours or tumour regions of each tumour line; 
the majority of tumours were found to have perfusion frac­
tions of 55% or higher. The mean perfusion fraction was 
about 60% for all tumour groups and the median perfusion 
fraction was usually considerably higher (55 75%). For indi­
vidual tumours low values for central and high values for 
peripheral perfusion fraction or vice versa were observed, 
although no significant differences in the mean tumour per­
fusion fraction between central and 
tumours belonging to one tumour line (paired Student’s t-
•/>ƒ■'t s in
o r tumours
be found (Tukey test), 
tumour
tumour
ï was no c
» an of characteristic
patterns in the vascular parameters RVA and PF, in Figure 4 
the mean RVA and PF are shown for individual tumours 
without vessels, as does tumour line E80. In E80 vessels are belonging to the lines E120, E80 and E49. These data clearly 
less numerous but larger and more elongated than in E l20 show a wide range of values for individual tumours for the
ously distributed in E l20. E l8 shows cyst-like formations
and E l8. In tumour line E98 many medium-sized tumour
thesse s are
tumour. In tumour line El 10 small vessels are present in the 
central area and larger, more elongated, vessels in the tumour
periphery. Tumours of E49 are characterised by long stretch­
ed vessels widely separated from each other in the tumour 
periphery with very few vessels in the tumour centre.
» in
tumour lines suggest that, although all xenografts originate 
from human
tumours induce different vascular patterns when xenotrans
in mice.
two vascular parameters but a tendency towards clustering 
can be seen for tumours belonging to the same tumour line. 
This indicates that the majority of tumours belonging to the 
same tumour line have tumour line-specific values for the 
combination of
from tumours derived from other lines.
:se tumours
tumour area
parent The relative perfused tumour area (RPTA) is defined as the
vascular area divided by the tumour area, thus
tumour area (Table II and Figure 3).
It is clear from Figure 3c that some tumour lines show a
0 , great variability (E18, E80, E98) in RPTA, while the varia-
( a ivc \cimu ar area tjon jn other tumour lines or tumour regions is limited (E49,
The ratio of the mean relative vascular area as determined by El20c and E120p). The mean values for all tumour lines 
the image analysis system varied from 7% to 14%» for the ranged from 0.045 to 0.085. Owing to the large variation,
724
Table II Vascular parameters for seven human glioma xenograft lines
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Turnout PF± s.(I.
__ _ . . .  ___ _____ -  _ .  - .
PF C V
(% )
RVA
(m e a n is .d .)
RVA CV
(% )
RPTA
(mean ± s.d. )
RPTA CV
(% )
Whole tumour
E2 0.58 ±0.16 28 0.08 ±0.02 21 0.049 ±0.02 41
E18 0.63 ±0.18 28 0.11 ±0.05 48 0.075 ±0.06 77
E49 0.63 ±0.21 33 0.07 ±0.02 28 0.044 ±0.01 34
E80 0.62 ±0.15 24 0.13 ± 0.04 27 0.085 ±0.03 38
E98 0.62 ±0.26 42 0.09 ±0.04 40 0.056 ±0.03 59
E110 0.56 ±0.12 21 0.13±0.03 22 0.072 ±0.03 :37
El 20 0.44 ±0.08 18 0.14±0.02 13 0.060 ±0.02 38
Central vs Peripheral
E2 c 0.55 + 0.18 33 0.07 ±0.02 23 0.042 ±0.02 48
P 0.61 ±0.15 25 0.09 ±0.02 17 0.055 ±0.02 35
El 8 c 0.61 ±0.20 33 0.09 ±0.05 52 0.059 ±0.04 75
P
c
0.66 ±0.20 30 0.12±0.08 61 0.090 ±0.07 77
E49 0.62 ±0.18 29 0.07 ±0.02 25 0.040 ±0.01 23
p 0.66 ±0.25 38 0.08 ±0.02 28 0.048 ±0.02 40
E80 c 0.60 ±0.16 27 0.13 ±0.04 28 0.079 ±0.03 41
p
c
0.65 ±0.16 25 0.14 ±0.04 30 0.091 ±0.03 36
E98 0.63 ± 0.22 35 0.09 ±0.04 43 0.057 ±0.03 60
p 0.60 ±0.28 47 0.09 ±0.03 38 0.055 ±0.03 63
E110 c 0.53 ±0.11 21 0.11 ±0.02 17 0.061 ±0.02 28
p 0.59 ±0.13 22 0.14±0.04 26 0.083 ±0.03 38
El 20 c 0.37 ±0.05 13 0.12 ± 0.01 10 0.046 ±0.01 13
p 0.52 ±0.15 29 0.14±0.02 13 0.074 ±0.03 34
Values are expressed as means±standard deviations. Data based on 5-7 tumours per line, 4-5 
complete sections per tumour location (peripheral or central), m, mean; CV, s.d./mean x 100%; 
c, central; p, peripheral; PF, perfusion fraction; RVA, relative vascular area; RPTA, relative 
perfused tumour area.
only the mean RPTA of E49 was significantly lower than the 
mean RPTA of E80; no other significant differences between 
the tumour lines for relative perfused tumour area (see Table 
III) were found (Tukey test). It can be seen in Figure 3c, 
however, that specific trends for tumour perfusion are pre­
sent. For example, both E49 and El 20 tend to have a low 
central perfused tumour area, with limited variation. 
Although not significant, the perfused tumour area of E98 is 
for most of these tumours lower than for tumours belonging 
to E80. It is important to realise that the heterogeneity in 
perfused tumour area as observed in these xenografts may 
have important consequences for tumour oxygenation and 
metabolism and thus explain differences in therapy re­
sponse.
Discussion
This study was designed to examine the variability in the 
degree of vascularisation and the perfusion of seven glioma 
xenografts of different origin. Our results suggest that consis­
tent differences in vascular parameters exist between the 
glioma xenograft lines, although the primary tumours were 
all high-grade human gliomas of similar histology. Tumour- 
specific vascular arrangements were present as well as specific 
trends for relative vascular area and perfusion fraction. As 
the vascular system is derived from the host animal, and as 
host animals and implantation site were the same for all 
tumour lines, the differences in vascular parameters must at 
least in part reflect differences in angiogenic properties of 
glioma cells derived from different primary human tumours. 
Thus, our observations underline the fact that the host tissue 
surrounding the tumour is not the only determining factor of 
the tumour vascular pattern. Several vascular parameters will 
be discussed separately below.
Relative vascular area/vascular architecture
Characteristic differences in mean relative vascular area and 
vascular architecture were noticed for the tumour lines 
originating from different primary tumours, although large 
intra-and inter-tumour variations were present. Certain
tumour lines were found to have a significantly higher degree 
of vascularisation than others. Some tumour lines showed a 
more homogeneous distribution of vessels, whereas others 
were characterised by a heterogeneous vascularisation, while 
individual vessel structures were also found to show tumour 
line-dependent appearances. These results are in agreement 
with the reports of Solesvik et al. (1982) and Kraus et al. 
(1983). Using stereological techniques Solesvik et al. (1982) 
demonstrated that in human melanoma xenografts growing 
subcutaneously in the nude mouse vascular parameters also 
show tumour line-specific characteristics. In their study the 
surface of tumour vessel structures filled with contrast 
medium, vessel diameter and total vessel length and vessel 
volume per unit histologically non-necrotic tumour volume 
varied significantly among the five different human 
melanoma lines. Kraus et al. (1983) described consistently 
different vascular patterns in microangiograms of tumours of 
ten different human tumour types implanted subcutaneously 
in the nude mouse. In animal tumours similar characteristic 
vascular patterns were found (Margualis et al., 1961; Milne 
et al., 1969). In contrast, no characteristic vascular density or 
vascular architecture of several human tumours (melanoma, 
six different sarcomas) transplanted subcutaneously in nude 
mice, as shown by India ink perfusion, could be found by 
Steinberg et al. (1990, 1991). In their study they found a very 
high degree of heterogeneity in tumour vessel distribution as 
well as great interindividual variation in tumour vessel dis­
tribution between tumours of the same tumour type. 
Differences in the techniques used to visualise and quantify 
tumour vessels can explain these differences in observations 
on tumour vascular structures. It is also possible that some 
tumour types are capable of developing a more characteristic 
vascular distribution than other types.
The differences in extent of vascularisation of tumours may 
well be associated with the capacity of the tumour cells to 
produce angiogenic growth factors such as basic fibroblast 
growth factor (bFGF) and vascular endothelial growth factor 
(VEGF). Indeed, recently Abe et al. (1993) reported 
differences in bFGF mRNA levels in various glioma cell lines 
and related these to a differential capacity to induce tube 
formation in vitro and develop capillary networks in mice 
when injected subcutaneously. Low mRNA levels in the 
tumour cells were associated with poorly vascularised
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Figure 3 (a) Relative vascular area for central and peripheral 
sections of seven glioma xenograft lines, (b) Perfusion fraction lor 
central and peripheral sections of seven glioma xenograft lines, 
(c) Relative perfused tumour area for central and peripheral 
sections of seven glioma xenograft 
represents the mean value of the four (peripheral or central)
; sections per tumour. The filled circles represent the 
mean of each group, the horizontal bars represent the median. 
The box indicates the mean ± 1 s.d. Abbreviations: PF, perfusion 
fraction (perfused vessel area/total vessel area); RPTA, relative
tumour area "sr* tumour area);
RVA, relative vascular area (total vessel area/total tumour area; 
c, central; p, peripheral; s.d. standard deviation.
tumours in the mice. Variations in angiogenic capacity may 
also be responsible for differences in vascular area and archi­
tecture seen in our tumour lines. It should be noted that, 
besides the angiogenic capacity of tumour cells, the degree of 
vascularisation and architecture of the vascular network are 
also influenced by a number of other factors, including the
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Relative vascular area
4 Mean perfusion fraction and mean relative vascular 
area of individual tumours belonging to three human glioma 
xenograft lines (A ,  E49; O , E80; H, E120) illustrating the char-
acteristic patterns for each of the lines (bars = s.d.).
Table III Statistical significance of differences in vascular parameters
for seven human glioma xenograft lines
RVA PF RPTA
Mean (E120, E110, E8Q)>(E49, E2) NS E80>E49
(El20, E80)>E98
Central (E120, E80)>E49 NS NS
Peripheral NS NS NS
Tukey test, J°<0.05. Data are derived from Table II. PF, perfusion 
fraction; RVA, relative vascular area; RPTA, relative perfused tumour 
area; NS, not significant.
neously in mice and found central avascular cavities in larger 
tumours. In our series we also found a tendency for the mean 
vascular area to be smaller in central areas than in peripheral 
regions. These differences were not very pronounced how­
ever. It is possible that different tumour types and variations 
in tumour size (our tumours being relatively small) can ex­
plain these differences.
”s,
Perfusion fraction/relative perfused tumour fraction
In our study the perfusion fraction of the vascular structures 
ranged from 20% to 85%. In most tumour lines only one or 
two tumours or tumour regions were found to have a low 
perfusion fraction (20-40%); the majority of tumours were 
shown to have perfusion fractions higher than 60%. There
a large inter-tumour variation, and tumour 
specific perfusion fractions were not observed. More 
specific trends were seen for the relative perfused tumour 
area in several tumour lines. This can be explained by the 
fact that, although the percentage of the perfused vessels may 
be in the same range for many tumour lines, 
vascular area (and architecture) result in differences of per­
fused tumour area. Lyng et al. (1992) also assumed in their 
study of six subcutaneously implanted human melanoma 
lines in nude mice that differences in blood supply per viable 
tumour cell were related to differences in vascular architec-
m
ture. The blood supply in their study was measured by 
uptake of 86Rb and clearance of lMXe.
Our results on tumour perfusion indicate that the number
interstitial pressure of the tumour, growth stage and site of of vessels per unit area is not the only determining factor for
tumour growth (Schulz-Hector et al. ,  1991 
1992).
et al., tissue perfusion as many vessels may not be functional. It is 
not clear what proportion of the non-perfused vessel areas is
It has been noted that central tumour areas may have a permanently or temporarily non-functional. The fact that
poorer vascular system (and blood supply) due to central 
necrosis and rarefaction of the blood vessels (Vaupel et al.
20 85% of the vascular structures are not perfused at a 
given time suggests that extensive areas of the tumours are
1989). In human tumours peripheral areas have also been hypoxic or not accessible by therapeutic agents, resulting in
shown to have a higher vascular density (Steinberg et al.,
1991). Grunt et al. a detailed
corrosion study of Lewis lung carcinoma growing subcuta
decreased therapeutic conditions. Even if only some of these 
vessels can be reperfused, this would then imply that access 
of therapeutic agents could be improved or tumour oxygena-
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tion increased, resulting in improved sensitivity to radio- nude mouse. Regional distribution of vessel structures and
therapy. vascular architecture can be analysed very efficiently using a
The link between the vascular parameters of the xenografts computer-based digital image processing system. This system
and their parent tumours in our study is difficult to establish offers the opportunity to quantify vascular profiles in whole
since the available tumour biopsies in most cases constitute tumour sections or to analyse regional differences. By com-
too small a part of the tumour to be representative. Lauk et paring the total vascular area with Hoechst-stained areas, the
al. (1989) compared morphometric data of the vascular net- perfused vascular area can be determined. In this way both
work in human squamous cell carcinomas and their xeno- structural and functional information can be obtained from
transplants in nude mice (subcutaneous) and concluded that the tumour vascular system. It is our expectation that a more
the spatial distribution of proliferating tumour cells as well as detailed analysis of individual vessel structures and inter-
differentiation characteristics appear to be retained in xeno- capillary distance will further extend our knowledge of the
graft tumours although the density of the vascular system vascularisation and perfusion of the xenografts and its con- 
appeared to be host specific. It was found that distances sequences for treatment and clinical behaviour, and studies in
between tumours cells and blood vessels in original tumours 
were significantly longer than in xeno transplants. This im­
plies that observations in tumour models, especially concern­
ing vascular systems, have to be interpreted carefully with 
regard to the clinical relevance, although good agreements do 
exist.
The combination of the use of a fluorescent perfusion 
marker (Hoechst 33342) and a basal lamina membrane 
marker (collagen type IV), as shown in this study, offers an 
excellent opportunity to analyse and grade angiogenesis and 
vascularity and to obtain information about the functional 
status of the vessels of human gliomas xenografted in the
this direction are in preparation.
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